Sun Pharma gets tentative FDA nod for generic Gleevec tablets
Press Trust of India / Mumbai Nov 17, 2009, 11:33 IST
Sun Pharmaceutical Industries today said it has got tentative approval from the US drug regulator for generic Gleevec (imatinib meyslate tablets), used in the treatment of chronic myeloid leukaemia.
The US Food and Drug Administration (USFDA) has granted tentative approval for the company's abbreviated new drug application (ANDA) for generic Gleevec, Sun Pharma said in a filing to the Bombay Stock Exchange (BSE).